Peroral Amphotericin B Polymer Nanoparticles Lead to Comparable or Superior in Vivo Antifungal Activity to That of Intravenous Ambisome® or Fungizone™
PLoS ONE - United States
doi 10.1371/journal.pone.0025744
Full Text
Open PDFAbstract
Available in full text
Categories
Date
October 6, 2011
Authors
Publisher
Public Library of Science (PLoS)